SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-15 12:34
Tx date 2024-04-12 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
+452,429 vol 		1,381,058
Filed 2024-04-02 16:44
Tx date 2024-04-02 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$3,530
+37,163 vol
$0.095 each 		917,870
Filed 2024-04-02 16:42
Tx date 2024-04-02 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-37,163 vol 		535,343
Filed 2024-01-02 16:53
Tx date 2023-12-29 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$2,695
+24,222 vol
$0.1113 each 		880,707
Filed 2023-11-30 17:33
Tx date 2023-11-28 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+1,450,000 vol 		1,776,860
Filed 2023-11-30 17:31
Tx date 2023-11-28 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+550,000 vol 		572,506
Filed 2023-11-30 17:29
Tx date 2023-11-29 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,750
+50,000 vol
$0.075 each 		856,485
Filed 2023-10-11 13:54
Tx date 2023-10-10 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+476,200 vol 		928,629
Filed 2023-10-11 13:52
Tx date 2023-10-10 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 12% Unsecured Convertible Debenture
11 - Acquisition or disposition carried out privately 		$
+$100 vol
$1,000 each 		$100
Filed 2023-10-11 13:50
Tx date 2020-04-07 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 12% Unsecured Convertible Debenture
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-01 13:37
Tx date 2023-04-28 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$3,368
+25,910 vol
$0.13 each 		806,485
Filed 2023-05-01 13:36
Tx date 2023-04-28 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-25,910 vol 		22,506
Filed 2023-04-05 14:47
Tx date 2023-04-05 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,900
+100,000 vol
$0.099 each 		780,575
Filed 2023-03-31 13:46
Tx date 2023-03-30 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-412,400 vol 		326,860
Filed 2023-03-31 13:42
Tx date 2023-03-30 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,067.13
-11,857 vol
$0.09 each 		680,575
Filed 2023-03-31 13:41
Tx date 2023-03-30 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$3,158
+37,162 vol
$0.085 each 		692,432
Filed 2023-03-31 13:39
Tx date 2023-03-30 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-37,162 vol 		48,416
Filed 2022-11-10 15:38
Tx date 2022-11-10 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,750
+50,000 vol
$0.135 each 		655,270
Filed 2022-09-20 15:44
Tx date 2022-09-20 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,900
+40,000 vol
$0.1225 each 		605,270
Filed 2022-09-15 16:26
Tx date 2022-09-15 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,150
+90,000 vol
$0.135 each 		565,270
Filed 2022-09-13 16:47
Tx date 2022-09-09 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,650
+30,000 vol
$0.155 each 		475,270
Filed 2022-05-05 12:17
Tx date 2022-05-02 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,936.32
-8,068 vol
$0.24 each 		445,270
Filed 2022-05-05 12:16
Tx date 2022-05-02 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$6,736
+25,909 vol
$0.26 each 		453,338
Filed 2022-05-05 12:15
Tx date 2022-05-02 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-25,909 vol 		85,578
Filed 2022-04-25 14:01
Tx date 2022-04-22 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
97 - Other
-100,000 vol 		739,260
Filed 2022-04-25 13:59
Tx date 2022-04-20 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Performance Share Units
56 - Grant of rights
+111,486 vol 		266,942
Filed 2022-04-25 13:58
Tx date 2022-04-20 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+111,487 vol 		111,487
Filed 2022-04-25 13:57
Tx date 2020-04-07 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-25 13:56
Tx date 2022-04-20 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+50,000 vol 		839,260
Filed 2021-05-03 18:55
Tx date 2021-04-28 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Performance Share Units
30 - Acquisition or disposition under a purchase/ownership plan
+155,456 vol 		155,456
Filed 2021-05-03 18:54
Tx date 2020-04-07 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-03 18:54
Tx date 2021-04-28 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$321,620
+200,000 vol
$1.61 each 		789,260
Filed 2021-04-08 18:08
Tx date 2021-03-01 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
+40,000 vol 		427,429
Filed 2021-04-08 18:07
Tx date 2021-03-01 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
-40,000 vol 		452,429
Filed 2020-10-30 17:42
Tx date 2020-10-29 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
+40,000 vol 		492,429
Filed 2020-10-30 17:41
Tx date 2020-10-29 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$52,000
+80,000 vol
$0.65 each 		387,429
Filed 2020-06-29 17:23
Tx date 2020-04-07 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		452,429
Filed 2020-06-29 17:22
Tx date 2020-04-07 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		589,260
Filed 2020-06-29 17:21
Tx date 2020-04-07 		$WLLW
Willow Biosciences Inc. 		Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		307,429